Nordic Nanovector ASA (DE:8NN) has released an update.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Thor Medical ASA has achieved a significant milestone by shipping its first Thorium-228 alpha-emitter samples from its new pilot facilities at Herøya, marking a step closer to commercial operations. This shipment is part of their strategy to transform cancer treatment with their innovative alpha-emitter technology and follows key achievements like a strategic supply agreement with ARTBIO. Investors and stakeholders will gain further insights during Thor Medical’s Capital Markets Update in Stockholm.
For further insights into DE:8NN stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Boeing (NYSE:BA) Layoffs Expand, Start Hitting Multiple Factories
- Microsoft’s (NASDAQ:MSFT) New Computer is Exclusively a Cloud Machine
- Walmart (NYSE:WMT) Warns About Tariff-Driven Price Hikes
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
